SOX2 and central nervous system cancer: Interestingly, when radiation was combined with the bi-(AID-1-T) aptamer treatment, the cells characterized by increased expression of the stemness factors CD133, L1CAM, EGFR, Casp3, p53, Nestin, Sox2, and CD44 had increased survival rate in primary gliomas (Figure 1G).